SCHEMBL7537476

SCHEMBL7537476

CON=C(c1cc(C)no1)c1ccccc1CON=C(C)c1ccc(Cl)c(Cl)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARG P37231 1/20 0.36
▸ PPARA Q07869 1/20 0.36
▸ NR1H4 Q96RI1 5/20 0.36
▸ HIF1A Q16665 1/20 0.35
▸ RAB9A P51151 4/20 0.33
▸ NPC1 O15118 3/20 0.33
▸ SLC6A2 P23975 1/20 0.33
▸ SLC6A4 P31645 1/20 0.33
▸ SLC6A3 Q01959 1/20 0.33
▸ MAPT P10636 3/20 0.32
▸ KMT2A Q03164 2/20 0.32
▸ PKM P14618 1/20 0.32
▸ POLB P06746 1/20 0.32
▸ DRD4 P21917 2/20 0.32
▸ DRD2 P14416 1/20 0.32
▸ HTT P42858 1/20 0.31
▸ TDP1 Q9NUW8 1/20 0.31
▸ MEN1 O00255 1/20 0.31
▸ LMNA P02545 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7537180 0.78 KMT2A (0.41) RAB9ANPC1KMT2APKMPOLB
SCHEMBL7542538 0.76 KMT2A (0.41) HIF1ARAB9ANPC1KMT2APKM
SCHEMBL23971812 0.73 HIF1A (0.50) PPARGPPARAHIF1ARAB9ANPC1
SCHEMBL7535658 0.72 MRGPRX4 (0.43) PPARGHIF1ARAB9APOLBLMNA
SCHEMBL7535896 0.72 MAPT (0.40) RAB9ANPC1MAPTKMT2AMEN1
SCHEMBL25552241 0.70 HIF1A (0.48) PPARGPPARAHIF1ARAB9ANPC1
SCHEMBL6811427 0.67 NPFFR2 (0.56) SLC6A4MAPTKMT2AMEN1SMN1; SMN2
SCHEMBL6811431 0.67 NPFFR2 (0.56) SLC6A4MAPTKMT2AMEN1SMN1; SMN2
SCHEMBL20698676 0.66 HIF1A (0.52) HIF1ARAB9ANPC1SLC6A2SLC6A4
SCHEMBL23971686 0.65 HIF1A (0.49) HIF1ARAB9ANPC1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6362212-B1 POTENT FUNGICIDAL ACTIVITY SHIONOGI & COMPANY, LTD. (JP) 2002-03-26 — — US disclosed
US-20020032227-A1 Oxime derivative and bactericide containing the same as active ingredient TAKASE AKIRA (JP) 2002-03-14 — — US disclosed
US-6268312-B1 FUNGICIDES SHIONOGI & CO., LTD. (JP) 2001-07-31 — — US disclosed
US-6048885-A FUNGICIDES SHIONOGI & CO., LTD. (JP) 2000-04-11 — — US disclosed
EP-0754684-A1 OXIME DERIVATIVE AND BACTERICIDE CONTAINING THE SAME AS ACTIVE INGREDIENT SHIONOGI & CO., LTD. (JP) 1997-01-22 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020032227-A1 Oxime derivative and bactericide containing the same as active ingredient MSMO1, O60361, CBR1 PPARG 2107/4885PPARA 2407/4885NR1H4 3470/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback